Which has higher valuation and earnings, WAY or DOCS?

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.13 $112.09M $0.70 33.83 Doximity $655.57M 6.81 $196.05M $0.85 29.46

Is WAY or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Doximity 25.48% 18.06% 15.40%

Does the media favor WAY or DOCS?

In the previous week, Waystar had 4 more articles in the media than Doximity. MarketBeat recorded 11 mentions for Waystar and 7 mentions for Doximity. Waystar's average media sentiment score of 1.79 beat Doximity's score of 0.80 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Doximity 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, DOCS or HTFL?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $655.57M 6.81 $196.05M $0.85 29.46 Heartflow $176.03M 24.68 -$116.79M -$1.83 N/A

Is DOCS or HTFL more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Heartflow -55.82% -23.52% -18.66%

Does the media prefer DOCS or HTFL?

In the previous week, Heartflow had 8 more articles in the media than Doximity. MarketBeat recorded 15 mentions for Heartflow and 7 mentions for Doximity. Doximity's average media sentiment score of 0.80 beat Heartflow's score of 0.60 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, SDGR or DOCS?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.65 -$103.26M -$0.74 N/A Doximity $655.57M 6.81 $196.05M $0.85 29.46

Is SDGR or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Doximity 25.48% 18.06% 15.40%

Does the media prefer SDGR or DOCS?

In the previous week, Schrodinger and Schrodinger both had 7 articles in the media. Schrodinger's average media sentiment score of 0.83 beat Doximity's score of 0.80 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, CERT or DOCS?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.97 -$1.60M -$0.45 N/A Doximity $655.57M 6.81 $196.05M $0.85 29.46

Is CERT or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Doximity 25.48% 18.06% 15.40%

Does the media prefer CERT or DOCS?

In the previous week, Doximity had 2 more articles in the media than Certara. MarketBeat recorded 7 mentions for Doximity and 5 mentions for Certara. Certara's average media sentiment score of 1.55 beat Doximity's score of 0.80 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Doximity 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, DOCS or GDRX?

Doximity has higher earnings, but lower revenue than GoodRx. Doximity is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $655.57M 6.81 $196.05M $0.85 29.46 GoodRx $796.85M 1.50 $30.44M $0.04 87.38

Is DOCS or GDRX more profitable?

Doximity has a net margin of 25.48% compared to GoodRx's net margin of 2.07%. Doximity's return on equity of 18.06% beat GoodRx's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% GoodRx 2.07% 7.22% 2.53%

Does the media refer more to DOCS or GDRX?

In the previous week, GoodRx had 1 more articles in the media than Doximity. MarketBeat recorded 8 mentions for GoodRx and 7 mentions for Doximity. Doximity's average media sentiment score of 0.80 beat GoodRx's score of 0.37 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Doximity (DOCS) Competitors

$25.04 +0.30 (+1.21%)

As of 10:01 AM Eastern

Compare

DOCS vs. WAY, HTFL, SDGR, CERT, and GDRX

Should you buy Doximity stock or one of its competitors? Doximity's main competitors and comparable companies include Waystar (WAY), Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Doximity compare to Waystar?

Waystar (NASDAQ:WAY) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Doximity	25.48%	18.06%	15.40%

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.13	$112.09M	$0.70	33.83
Doximity	$655.57M	6.81	$196.05M	$0.85	29.46

87.2% of Doximity shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Waystar has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market. Comparatively, Doximity has a beta of 1.29, meaning that its share price is 29% more volatile than the broader market.

Waystar currently has a consensus target price of $35.00, indicating a potential upside of 47.80%. Doximity has a consensus target price of $32.43, indicating a potential upside of 29.51%. Given Waystar's stronger consensus rating and higher probable upside, equities research analysts plainly believe Waystar is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1 Sell rating(s)	2 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.96
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28

In the previous week, Waystar had 4 more articles in the media than Doximity. MarketBeat recorded 11 mentions for Waystar and 7 mentions for Doximity. Waystar's average media sentiment score of 1.79 beat Doximity's score of 0.80 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Waystar on 9 of the 17 factors compared between the two stocks.

How does Doximity compare to Heartflow?

Doximity (NYSE:DOCS) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Doximity currently has a consensus target price of $32.43, indicating a potential upside of 29.51%. Heartflow has a consensus target price of $43.43, indicating a potential downside of 13.10%. Given Doximity's higher possible upside, equities analysts plainly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Heartflow had 8 more articles in the media than Doximity. MarketBeat recorded 15 mentions for Heartflow and 7 mentions for Doximity. Doximity's average media sentiment score of 0.80 beat Heartflow's score of 0.60 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Heartflow	-55.82%	-23.52%	-18.66%

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$655.57M	6.81	$196.05M	$0.85	29.46
Heartflow	$176.03M	24.68	-$116.79M	-$1.83	N/A

Summary

Doximity beats Heartflow on 12 of the 16 factors compared between the two stocks.

How does Doximity compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

Schrodinger has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market.

In the previous week, Schrodinger and Schrodinger both had 7 articles in the media. Schrodinger's average media sentiment score of 0.83 beat Doximity's score of 0.80 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Doximity	25.48%	18.06%	15.40%

Schrodinger currently has a consensus price target of $20.50, indicating a potential upside of 4.76%. Doximity has a consensus price target of $32.43, indicating a potential upside of 29.51%. Given Doximity's higher probable upside, analysts clearly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.65	-$103.26M	-$0.74	N/A
Doximity	$655.57M	6.81	$196.05M	$0.85	29.46

Summary

Doximity beats Schrodinger on 13 of the 16 factors compared between the two stocks.

How does Doximity compare to Certara?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

74.0% of Certara shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Certara presently has a consensus target price of $8.28, indicating a potential upside of 1.63%. Doximity has a consensus target price of $32.43, indicating a potential upside of 29.51%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28

Certara has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

In the previous week, Doximity had 2 more articles in the media than Certara. MarketBeat recorded 7 mentions for Doximity and 5 mentions for Certara. Certara's average media sentiment score of 1.55 beat Doximity's score of 0.80 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.97	-$1.60M	-$0.45	N/A
Doximity	$655.57M	6.81	$196.05M	$0.85	29.46

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Doximity	25.48%	18.06%	15.40%

Summary

Doximity beats Certara on 14 of the 17 factors compared between the two stocks.

How does Doximity compare to GoodRx?

Doximity (NYSE:DOCS) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Doximity has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

87.2% of Doximity shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 31.8% of Doximity shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Doximity has a net margin of 25.48% compared to GoodRx's net margin of 2.07%. Doximity's return on equity of 18.06% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
GoodRx	2.07%	7.22%	2.53%

Doximity presently has a consensus price target of $32.43, indicating a potential upside of 29.51%. GoodRx has a consensus price target of $4.23, indicating a potential upside of 20.95%. Given Doximity's stronger consensus rating and higher possible upside, research analysts clearly believe Doximity is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Doximity has higher earnings, but lower revenue than GoodRx. Doximity is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$655.57M	6.81	$196.05M	$0.85	29.46
GoodRx	$796.85M	1.50	$30.44M	$0.04	87.38

In the previous week, GoodRx had 1 more articles in the media than Doximity. MarketBeat recorded 8 mentions for GoodRx and 7 mentions for Doximity. Doximity's average media sentiment score of 0.80 beat GoodRx's score of 0.37 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Doximity beats GoodRx on 13 of the 17 factors compared between the two stocks.

Get Doximity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOCS vs. The Competition

Export

Metric	Doximity	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.46B	$1.67B	$7.29B	$24.31B
Dividend Yield	N/A	4.69%	2.53%	3.70%
P/E Ratio	29.46	21.13	271.74	30.34
Price / Sales	6.81	78.26	618.25	20.52
Price / Cash	20.41	31.64	78.57	32.63
Price / Book	4.87	7.09	13.03	7.70
Net Income	$196.05M	-$26.60M	$3.46B	$1.07B
7 Day Performance	-2.98%	-0.71%	1.22%	0.08%
1 Month Performance	22.60%	12.57%	8.48%	3.17%
1 Year Performance	N/A	-16.10%	25.36%	14.90%

Doximity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOCS Doximity	4.8177 of 5 stars	$25.04 +1.2%	$32.43 +29.5%	N/A	$4.46B	$655.57M	29.46	890
WAY Waystar	4.67 of 5 stars	$25.01 flat	$35.00 +39.9%	-32.6%	$4.80B	$1.10B	35.73	1,700	News Coverage Analyst Forecast
HTFL Heartflow	2.0899 of 5 stars	$49.75 flat	$43.43 -12.7%	+67.2%	$4.33B	$176.03M	N/A	699	Insider Trade
SDGR Schrodinger	1.3588 of 5 stars	$19.71 flat	$20.50 +4.0%	+2.3%	$1.46B	$259.04M	N/A	790
CERT Certara	2.1692 of 5 stars	$8.43 flat	$8.28 -1.8%	-24.7%	$1.29B	$421.75M	N/A	1,576	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DOCS) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Doximity (DOCS) Competitors